Cargando…

Bio-Imaging of Colorectal Cancer Models Using Near Infrared Labeled Epidermal Growth Factor

Novel strategies that target the epidermal growth factor receptor (EGFR) have led to the clinical development of monoclonal antibodies, which treat metastatic colorectal cancer (mCRC) but only subgroups of patients with increased wild type KRAS and EGFR gene copy, respond to these agents. Furthermor...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Gadi, Lecht, Shimon, Arien-Zakay, Hadar, Ettinger, Keren, Amsalem, Orit, Oron-Herman, Mor, Yavin, Eylon, Prus, Diana, Benita, Simon, Nissan, Aviram, Lazarovici, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493605/
https://www.ncbi.nlm.nih.gov/pubmed/23144978
http://dx.doi.org/10.1371/journal.pone.0048803
_version_ 1782249296290119680
author Cohen, Gadi
Lecht, Shimon
Arien-Zakay, Hadar
Ettinger, Keren
Amsalem, Orit
Oron-Herman, Mor
Yavin, Eylon
Prus, Diana
Benita, Simon
Nissan, Aviram
Lazarovici, Philip
author_facet Cohen, Gadi
Lecht, Shimon
Arien-Zakay, Hadar
Ettinger, Keren
Amsalem, Orit
Oron-Herman, Mor
Yavin, Eylon
Prus, Diana
Benita, Simon
Nissan, Aviram
Lazarovici, Philip
author_sort Cohen, Gadi
collection PubMed
description Novel strategies that target the epidermal growth factor receptor (EGFR) have led to the clinical development of monoclonal antibodies, which treat metastatic colorectal cancer (mCRC) but only subgroups of patients with increased wild type KRAS and EGFR gene copy, respond to these agents. Furthermore, resistance to EGFR blockade inevitably occurred, making future therapy difficult. Novel bio-imaging (BOI) methods may assist in quantization of EGFR in mCRC tissue thus complementing the immunohistochemistry methodology, in guiding the future treatment of these patients. The aim of the present study was to explore the usefulness of near infrared-labeled EGF (EGF-NIR) for bio-imaging of CRC using in vitro and in vivo orthotopic tumor CRC models and ex vivo human CRC tissues. We describe the preparation and characterization of EGF-NIR and investigate binding, using BOI of a panel of CRC cell culture models resembling heterogeneity of human CRC tissues. EGF-NIR was specifically and selectively bound by EGFR expressing CRC cells, the intensity of EGF-NIR signal to background ratio (SBR) reflected EGFR levels, dose-response and time course imaging experiments provided optimal conditions for quantization of EGFR levels by BOI. EGF-NIR imaging of mice with HT-29 orthotopic CRC tumor indicated that EGF-NIR is more slowly cleared from the tumor and the highest SBR between tumor and normal adjacent tissue was achieved two days post-injection. Furthermore, images of dissected tissues demonstrated accumulation of EGF-NIR in the tumor and liver. EGF-NIR specifically and strongly labeled EGFR positive human CRC tissues while adjacent CRC tissue and EGFR negative tissues expressed weak NIR signals. This study emphasizes the use of EGF-NIR for preclinical studies. Combined with other methods, EGF-NIR could provide an additional bio-imaging specific tool in the standardization of measurements of EGFR expression in CRC tissues.
format Online
Article
Text
id pubmed-3493605
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34936052012-11-09 Bio-Imaging of Colorectal Cancer Models Using Near Infrared Labeled Epidermal Growth Factor Cohen, Gadi Lecht, Shimon Arien-Zakay, Hadar Ettinger, Keren Amsalem, Orit Oron-Herman, Mor Yavin, Eylon Prus, Diana Benita, Simon Nissan, Aviram Lazarovici, Philip PLoS One Research Article Novel strategies that target the epidermal growth factor receptor (EGFR) have led to the clinical development of monoclonal antibodies, which treat metastatic colorectal cancer (mCRC) but only subgroups of patients with increased wild type KRAS and EGFR gene copy, respond to these agents. Furthermore, resistance to EGFR blockade inevitably occurred, making future therapy difficult. Novel bio-imaging (BOI) methods may assist in quantization of EGFR in mCRC tissue thus complementing the immunohistochemistry methodology, in guiding the future treatment of these patients. The aim of the present study was to explore the usefulness of near infrared-labeled EGF (EGF-NIR) for bio-imaging of CRC using in vitro and in vivo orthotopic tumor CRC models and ex vivo human CRC tissues. We describe the preparation and characterization of EGF-NIR and investigate binding, using BOI of a panel of CRC cell culture models resembling heterogeneity of human CRC tissues. EGF-NIR was specifically and selectively bound by EGFR expressing CRC cells, the intensity of EGF-NIR signal to background ratio (SBR) reflected EGFR levels, dose-response and time course imaging experiments provided optimal conditions for quantization of EGFR levels by BOI. EGF-NIR imaging of mice with HT-29 orthotopic CRC tumor indicated that EGF-NIR is more slowly cleared from the tumor and the highest SBR between tumor and normal adjacent tissue was achieved two days post-injection. Furthermore, images of dissected tissues demonstrated accumulation of EGF-NIR in the tumor and liver. EGF-NIR specifically and strongly labeled EGFR positive human CRC tissues while adjacent CRC tissue and EGFR negative tissues expressed weak NIR signals. This study emphasizes the use of EGF-NIR for preclinical studies. Combined with other methods, EGF-NIR could provide an additional bio-imaging specific tool in the standardization of measurements of EGFR expression in CRC tissues. Public Library of Science 2012-11-08 /pmc/articles/PMC3493605/ /pubmed/23144978 http://dx.doi.org/10.1371/journal.pone.0048803 Text en © 2012 Cohen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Cohen, Gadi
Lecht, Shimon
Arien-Zakay, Hadar
Ettinger, Keren
Amsalem, Orit
Oron-Herman, Mor
Yavin, Eylon
Prus, Diana
Benita, Simon
Nissan, Aviram
Lazarovici, Philip
Bio-Imaging of Colorectal Cancer Models Using Near Infrared Labeled Epidermal Growth Factor
title Bio-Imaging of Colorectal Cancer Models Using Near Infrared Labeled Epidermal Growth Factor
title_full Bio-Imaging of Colorectal Cancer Models Using Near Infrared Labeled Epidermal Growth Factor
title_fullStr Bio-Imaging of Colorectal Cancer Models Using Near Infrared Labeled Epidermal Growth Factor
title_full_unstemmed Bio-Imaging of Colorectal Cancer Models Using Near Infrared Labeled Epidermal Growth Factor
title_short Bio-Imaging of Colorectal Cancer Models Using Near Infrared Labeled Epidermal Growth Factor
title_sort bio-imaging of colorectal cancer models using near infrared labeled epidermal growth factor
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493605/
https://www.ncbi.nlm.nih.gov/pubmed/23144978
http://dx.doi.org/10.1371/journal.pone.0048803
work_keys_str_mv AT cohengadi bioimagingofcolorectalcancermodelsusingnearinfraredlabeledepidermalgrowthfactor
AT lechtshimon bioimagingofcolorectalcancermodelsusingnearinfraredlabeledepidermalgrowthfactor
AT arienzakayhadar bioimagingofcolorectalcancermodelsusingnearinfraredlabeledepidermalgrowthfactor
AT ettingerkeren bioimagingofcolorectalcancermodelsusingnearinfraredlabeledepidermalgrowthfactor
AT amsalemorit bioimagingofcolorectalcancermodelsusingnearinfraredlabeledepidermalgrowthfactor
AT oronhermanmor bioimagingofcolorectalcancermodelsusingnearinfraredlabeledepidermalgrowthfactor
AT yavineylon bioimagingofcolorectalcancermodelsusingnearinfraredlabeledepidermalgrowthfactor
AT prusdiana bioimagingofcolorectalcancermodelsusingnearinfraredlabeledepidermalgrowthfactor
AT benitasimon bioimagingofcolorectalcancermodelsusingnearinfraredlabeledepidermalgrowthfactor
AT nissanaviram bioimagingofcolorectalcancermodelsusingnearinfraredlabeledepidermalgrowthfactor
AT lazaroviciphilip bioimagingofcolorectalcancermodelsusingnearinfraredlabeledepidermalgrowthfactor